Among the 32 compounds that most strongly reduced bioluminescence, 31 did not alter persister frequencies, indicating that they probably suppressed bacterial metabolism rather than killing persisters (Supplementary Fig
They were not reducing their blood sugar levels more quickly
While numerous other GLP1 receptor agonists have since been developed for the management of diabetes, it wasnt until 2014 that a GLP1 receptor agonist, Saxenda (liraglutide), was approved for obesity (liraglutide had previously been approved for diabetes under the name Victoza)
Dzau, V
M., Isermann, P., McGregor, A
In the HARMONY-2 (efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide) clinical study, patients were randomized to receive either once-weekly albiglutide (30 mg, titrated up to 50 mg if required for glycemic control) or 10 units of insulin glargine once daily